Compared to patients retained in care, patients who died during follow-up tended to be aged ≥45 years (n = 44; 41% versus n = 412; 34%), were more frequently underweight (n = 36; 34% versus n = 184; 15%), and were more likely to have low CD4 cell count <100 cells/μL (n = 56; 52% versus n = 262; 22%), WHO stage 3/4 (n = 81; 76% versus n = 485; 40%), and co-morbidities (i.e., tuberculosis (n = 37; 35% versus n = 191; 16%) and anaemia (n = 85; 79% versus n = 634; 53%)). Here, CD4 is linked to tuberculosis.